Discovery at the interface of computation, biology, and translation

Partner with SIDD to accelerate therapeutic discovery.

The Sealy Institute for Drug Discovery (SIDD) collaborates with academic labs, biotech startups, and pharmaceutical partners to rapidly translate scientific ideas into therapeutic programs. Our teams combine computation, experimental biology, and translational expertise to move discoveries from concept to candidate.

• Industry and biotech drug discovery collaborations
• AI-guided molecular design and computational pipelines
• Translational programs spanning biologics, peptides, and small molecules

Partnership-Ready Discovery

Bring SIDD into the room early.

SIDD is built to help partners move from promising science to actionable discovery strategy quickly — before time, capital, and experiments are spent in the wrong direction.

Discuss a Partnership

For Biotech & Pharma

Collaborate with SIDD investigators to de-risk early discovery programs, explore new therapeutic modalities, and prioritize candidates with rigorous computational and experimental insight.

For Academic Investigators

Partner with SIDD to convert disease biology, molecular mechanisms, and promising targets into structured discovery programs with translational momentum.

For Strategic Partners

Engage SIDD around platform-building opportunities, sponsored research, technology development, and long-term discovery alliances.

SIDD research team gathered outside the research building Laboratory researcher performing bench work Research presentation in a SIDD facility

Research Focus

Integrated discovery platforms for modern therapeutics

SIDD combines deep computational expertise with collaborative biomedical research to support discovery, optimization, and translation across diverse therapeutic modalities.

Computational Drug Discovery

Advanced molecular modeling, docking, simulation, and AI-guided design workflows accelerate therapeutic discovery from concept to candidate.

Peptide & Biomolecular Engineering

Design and evaluation of peptides, biomaterials, and targeted molecular systems for translational biomedical applications.

Translational Research

Bridging high-impact computation with experimental collaboration to move promising discoveries toward real-world outcomes.

Investigators

Meet the scientists shaping SIDD research programs

SIDD brings together investigators spanning translational biology, therapeutic antibodies, oligonucleotide medicines, neuroimmune biomaterials, neurodegeneration, medicinal chemistry, and AI-guided molecular discovery.

Why Partner With SIDD

Scientific depth, translational focus, and discovery infrastructure in one institute.

SIDD helps partners clarify targets, evaluate molecular strategies, and prioritize next steps using a coordinated mix of computational modeling, experimental insight, and therapeutic-domain expertise.

Computational triage before costly experimental investment
Integrated therapeutic platforms across antibodies, oligonucleotides, peptides, and small molecules
Translational strategy from mechanism to candidate selection

About SIDD

Computation as a catalyst for biomedical innovation

The Sealy Institute for Drug Discovery provides an environment where interdisciplinary teams can combine chemistry, biology, computation, and translational insight to accelerate the path from molecular concept to therapeutic opportunity.

Opportunities

Research partnerships, training, and collaborative growth

Whether supporting students, collaborating with investigators, or engaging translational partners, SIDD is structured to amplify scientific momentum and enable ambitious discovery programs.

Get in Touch

Interested in collaborating with SIDD?

Reach out to discuss research collaborations, translational initiatives, student opportunities, or institutional partnerships.